Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Delivery to the gut microbiota: A rapidly proliferating research field.

Seifert A, Kashi Y, Livney YD.

Adv Colloid Interface Sci. 2019 Dec;274:102038. doi: 10.1016/j.cis.2019.102038. Epub 2019 Oct 18. Review.

PMID:
31683191
2.

Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo.

Engelberg S, Netzer E, Assaraf YG, Livney YD.

Cell Death Dis. 2019 Sep 20;10(10):702. doi: 10.1038/s41419-019-1870-0.

3.

Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer.

Edelman R, Assaraf YG, Slavkin A, Dolev T, Shahar T, Livney YD.

Pharmaceutics. 2019 May 5;11(5). pii: E216. doi: 10.3390/pharmaceutics11050216.

4.

β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer.

Bar-Zeev M, Kelmansky D, Assaraf YG, Livney YD.

Eur J Pharm Biopharm. 2018 Dec;133:240-249. doi: 10.1016/j.ejpb.2018.10.018. Epub 2018 Oct 24.

PMID:
30367935
5.

Cancer cell-selective, clathrin-mediated endocytosis of aptamer decorated nanoparticles.

Engelberg S, Modrejewski J, Walter JG, Livney YD, Assaraf YG.

Oncotarget. 2018 Apr 20;9(30):20993-21006. doi: 10.18632/oncotarget.24772. eCollection 2018 Apr 20.

6.

Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.

Bar-Zeev M, Livney YD, Assaraf YG.

Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21. Review.

PMID:
28867241
7.

Albumin and Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded with Paclitaxel for Biomedical Applications.

Vismara E, Bongio C, Coletti A, Edelman R, Serafini A, Mauri M, Simonutti R, Bertini S, Urso E, Assaraf YG, Livney YD.

Molecules. 2017 Jun 22;22(7). pii: E1030. doi: 10.3390/molecules22071030.

8.

Re-assembled casein micelles improve in vitro bioavailability of vitamin D in a Caco-2 cell model.

Cohen Y, Levi M, Lesmes U, Margier M, Reboul E, Livney YD.

Food Funct. 2017 Jun 1;8(6):2133-2141. doi: 10.1039/c7fo00323d. Epub 2017 May 17.

PMID:
28513755
9.

Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.

Edelman R, Assaraf YG, Levitzky I, Shahar T, Livney YD.

Oncotarget. 2017 Apr 11;8(15):24337-24353. doi: 10.18632/oncotarget.15363.

10.
11.

Bioavailability, rheology and sensory evaluation of fat-free yogurt enriched with VD3 encapsulated in re-assembled casein micelles.

Levinson Y, Ish-Shalom S, Segal E, Livney YD.

Food Funct. 2016 Mar;7(3):1477-82. doi: 10.1039/c5fo01111f.

PMID:
26878710
12.

The effect of sugar stereochemistry on protein self-assembly: the case of β-casein micellization in different aldohexose solutions.

Setter O, Livney YD.

Phys Chem Chem Phys. 2015 Feb 7;17(5):3599-606. doi: 10.1039/c4cp03686g. Epub 2015 Jan 2.

PMID:
25553611
13.

Rationally designed nanovehicles to overcome cancer chemoresistance.

Livney YD, Assaraf YG.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1716-30. doi: 10.1016/j.addr.2013.08.006. Epub 2013 Aug 15. Review.

PMID:
23954781
14.

Mechanisms of saccharide protection against epigallocatechin-3-gallate deterioration in aqueous solutions.

Shpigelman A, Zisapel A, Cohen Y, Livney YD.

Food Chem. 2013 Aug 15;139(1-4):1105-12. doi: 10.1016/j.foodchem.2013.01.022. Epub 2013 Jan 23.

PMID:
23561215
15.

Stability and bioavailability of vitamin D nanoencapsulated in casein micelles.

Haham M, Ish-Shalom S, Nodelman M, Duek I, Segal E, Kustanovich M, Livney YD.

Food Funct. 2012 Jul;3(7):737-44. doi: 10.1039/c2fo10249h. Epub 2012 May 9.

PMID:
22569895
16.

Maillard-conjugate based core-shell co-assemblies for nanoencapsulation of hydrophobic nutraceuticals in clear beverages.

Markman G, Livney YD.

Food Funct. 2012 Mar;3(3):262-70. doi: 10.1039/c1fo10220f. Epub 2011 Dec 22.

PMID:
22193634
17.

β-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: stability, target-activated release and cytotoxicity.

Shapira A, Davidson I, Avni N, Assaraf YG, Livney YD.

Eur J Pharm Biopharm. 2012 Feb;80(2):298-305. doi: 10.1016/j.ejpb.2011.10.022. Epub 2011 Nov 9.

PMID:
22085654
18.

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

Shapira A, Livney YD, Broxterman HJ, Assaraf YG.

Drug Resist Updat. 2011 Jun;14(3):150-63. doi: 10.1016/j.drup.2011.01.003. Epub 2011 Feb 16. Review.

PMID:
21330184
19.

Beta-casein nanoparticles as an oral delivery system for chemotherapeutic drugs: impact of drug structure and properties on co-assembly.

Shapira A, Assaraf YG, Epstein D, Livney YD.

Pharm Res. 2010 Oct;27(10):2175-86. doi: 10.1007/s11095-010-0222-7. Epub 2010 Aug 12.

PMID:
20703895
20.

Beta-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity.

Shapira A, Markman G, Assaraf YG, Livney YD.

Nanomedicine. 2010 Aug;6(4):547-55. doi: 10.1016/j.nano.2010.01.003. Epub 2010 Jan 25.

PMID:
20100598

Supplemental Content

Loading ...
Support Center